Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
Journal of Chemical Information and Modeling · 13.11.2023 · 63 (21) · 6900-6911
DOI: 10.1021/acs.jcim.3c01064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 01.11.2023. Verfasst von Lorenzo Guidetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy. Hauptthemen laut MEDLINE: Receptor, EphA2, Receptor, EphB2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Regione Emilia-Romagna.
Abstract (Originalsprache)
With the aim of identifying novel antagonists selective for the EphA receptor family, a combined experimental and computational approach was taken to investigate the molecular basis of the recognition between a prototypical Eph-ephrin antagonist (UniPR1447) and two representative receptors of the EphA and EphB subfamilies, namely, EphA2 and EphB2 receptors. The conformational free-energy surface (FES) of the binding state of UniPR1447 within the ligand binding domain of EphA2 and EphB2, reconstructed from molecular dynamics (MD) simulations performed on the microsecond time scale, was exploited to drive the design and synthesis of a novel antagonist selective for EphA2 over the EphB2 receptor. The availability of compounds with this pharmacological profile will help discriminate the importance of these two receptors in the insurgence and progression of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli Studi di Parma, Parco Area delle Scienze 27/A, I- 43124 Parma, Italy.
- Microbiome Research Hub, Università degli Studi di Parma, Parco Area delle scienze 11/A, I- 43124 Parma, Italy.
- Dipartimento di Medicina Molecolare Traslazionale, Università degli Studi di Brescia, Brescia 25121, Italy.
ORCID-Profile: Lorenzo Guidetti, Laura Scalvini, Riccardo Castelli, Francesca Galvani, Federica Vacondio, Silvia Rivara, Marco Mor, Alessio Lodola
Förderung
- Associazione Italiana per la Ricerca sul Cancro
- Regione Emilia-Romagna
Zitieren
APA
Guidetti, L., Zappia, A., Scalvini, L., Ferrari, F. R., Giorgio, C., Castelli, R., Galvani, F., Vacondio, F., Rivara, S., Mor, M., Urbinati, C., Rusnati, M., Tognolini, M., & Lodola, A. (2023). Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity. Journal of Chemical Information and Modeling, 63(21), 6900-6911. https://doi.org/10.1021/acs.jcim.3c01064
Vancouver
Guidetti L, Zappia A, Scalvini L, Ferrari FR, Giorgio C, Castelli R, et al. Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity. Journal of Chemical Information and Modeling. 2023;63(21):6900-6911. doi:10.1021/acs.jcim.3c01064
BibTeX
@article{Guidetti2023,
author = {Guidetti, Lorenzo and Zappia, Alfonso and Scalvini, Laura and Ferrari, Francesca Romana and Giorgio, Carmine and Castelli, Riccardo and Galvani, Francesca and Vacondio, Federica and Rivara, Silvia and Mor, Marco and Urbinati, Chiara and Rusnati, Marco and Tognolini, Massimiliano and Lodola, Alessio},
title = {Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity},
journal = {Journal of Chemical Information and Modeling},
year = {2023},
volume = {63},
number = {21},
pages = {6900--6911},
doi = {10.1021/acs.jcim.3c01064}
}
EUVIMED